Skip to main content
. 2020 Aug 12;21(16):5783. doi: 10.3390/ijms21165783
AA Arachidonic acid
AD Alzheimer’s disease
ALX/FPR Lipoxin A4/formyl peptide receptor
APP Amyloid precursor protein
Amyloid-beta
BBB Blood-brain barrier
BLT Leukotriene B4 receptor
ChemR Chemerin receptor
CNS Central nervous system
COX Cyclooxygenase
CSF Cerebrospinal fluid
DHA docosahexaenoic
EPA eicosapenraenoic
GPCR G protein-coupled receptor
GPR G protein receptor
LGR Leucine-rich repeat containing G protein-coupled receptor
LT Leukotriene
LOX Lipoxygenase
LXA4 Lipoxin A4
MaR1 Maresin 1
MCI Mild cognitive impairment
MMSE Mini-Mental State Examination
MRI Magnetic resonance imaging
NMDA N-methyl-D-aspartate
NPD1 Neuroprotectin D1
NSAIDs Non-steroidal anti-inflammatory drugs
PET Positron emission tomography
PG Prostaglandin
PPAR Peroxisome proliferator-activated receptor
PUFA Polyunsaturated fatty acid
RORα Retinoic acid-related orphan receptor α
RvD1 Resolvin D1
RvE1 Resolvin E1
SPECT Single photon emission computed tomography
SPM Specialized pro-resolving lipid mediator
TX Thromboxane